Phone: 732-445-3831, ext. 214
Ph.D., Institute of Physiology, Ukrainian Academy of Sciences, 1984
Professional Summary/CV [.PDF]
Department of Pharmaceutics, Ernest Mario School of Pharmacy, New Brunswick; Rutgers
Areas of Interest
Drug Delivery Systems, Preclinical Evaluation of Anticancer Drugs, and Biopharmaceutics.
Memberships and Professional Service
Guest Editor, Theme Issue “Intracellular Drug Delivery”, Pharmaceutical Research, 2007; Member, Discovery and Development Special Emphasis Panel (DHHS) Study Section of Center for Scientific Review at the NIH, 2007-present; Member: American Chemical Society, The International Society for Preventive Oncology, New Jersey Center for Biomaterials, New Jersey Cancer Institute.
Grants, Honors, and Awards
Principal Investigator, National Institute of Health/National Cancer Institute, "Molecular targeting of drug delivery system to cancer," 2006-2011; Principal Investigator, National Institute of Health/National Cancer Institute, "Targeted Proapoptotic Anticancer Drug Delivery System," 2004-2008; The Jorge Heller Journal of Controlled Release/Controlled Release Society Outstanding Paper Award, 1998; Awards of the Biology and Theoretical Medicine Section of the Ukranian Academy of Sciences, 1984, 1988, and 1993.
Academic Interests and Plans
My academic interests include: drug delivery; biopharmaceutics; nanotechnology for cancer detection and treatment; molecular targeting; antisense oligonucleotides, siRNA and peptides in cancer therapy; mechanisms of multidrug resistance; intracellular fate and molecular mechanisms of action of anticancer drugs: apoptosis and necrosis, signal transduction, antiapoptotic cellular defensive mechanisms; use of macromolecules for drug delivery; preclinical evaluation of anticancer drugs; tumor hypoxia; and modulation of cell death mechanisms during hypoxia.